Filing Flows › Ocugen (OCGN) › Q3 2026
Ocugen (OCGN) Q3 2026 earnings results (third quarter 2026)
10-Q filed Nov 4, 2026
Ocugen (OCGN) reported revenue of $2.0M for the third quarter 2026 (Q3 2026), +11% from a year earlier and +31% from the quarter before. Operating margin was -909.9%, net loss $3.6M (184.4% of revenue).
Ocugen, Q3 2026: revenue $2.0M (+11% year over year), operating margin -909.9%, net loss $3.6M, operating cash flow −$15.7M. The chart follows the revenue to costs, profit and cash.
| Q3 2026 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $2.0M | +31% | +11% |
| Operating profit | −$17.8M | — | — |
| Net earnings | −$3.6M | — | — |
| Operating cash flow | −$15.7M | — | — |
What changed
Revenue was $2.0M in Q3 2026, up 11% year over year and up 31% from the previous quarter.
Operating costs exceeded revenue by $17.8M, an operating margin of -909.9%. Total costs grew 2% against revenue growth of 11%. The fastest-growing cost line was Research & development (+12%). The quarter ended with a net loss of $3.6M, narrower than the previous quarter's $24.9M loss. Non-operating items added $14.2M, -393% of pre-tax earnings, so the bottom line overstates operating performance.
Operating cash flow was −$15.7M. Non-cash charges added back $500K of depreciation and $2.0M of share-based compensation. Working capital and other items used $14.6M. Capital expenditures of $149K exceeded it, leaving free cash flow of −$15.9M.
Questions
What was Ocugen's revenue in the third quarter 2026?
Ocugen (OCGN) reported revenue of $2.0M for the third quarter 2026 (Q3 2026), +11% from a year earlier and +31% from the quarter before.
Was Ocugen profitable in the third quarter 2026?
Operating loss was $17.8M (-909.9% of revenue) and net loss $3.6M.
Source: Ocugen 10-Q on SEC EDGAR.